121 related articles for article (PubMed ID: 16053847)
1. The role of gamma-PET in the evaluation of patients with recurrent squamous cell cancer of the head and neck.
Goshen E; Yahalom R; Talmi YP; Rotenberg G; Oksman Y; Zwas ST
Int J Oral Maxillofac Surg; 2005 Jun; 34(4):386-90. PubMed ID: 16053847
[TBL] [Abstract][Full Text] [Related]
2. High incidence of chest malignancy detected by FDG PET in patients suspected of recurrent squamous cell carcinoma of the upper aerodigestive tract.
Perlow A; Bui C; Shreve P; Sundgren PC; Teknos TN; Mukherji SK
J Comput Assist Tomogr; 2004; 28(5):704-9. PubMed ID: 15480048
[TBL] [Abstract][Full Text] [Related]
3.
Han EJ; O JH; Yoo IR; Kim YS; Kim MS; Kang JH; Choi WH
Hell J Nucl Med; 2017; 20(2):134-140. PubMed ID: 28697190
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of intrathoracic lesions detected by 18F-fluorodeoxyglucose positron emission tomography in the management of patients with head and neck cancer.
Roh JL; Ryu CH; Kim JS; Lee JS; Choi SH; Nam SY; Kim SY
Oral Oncol; 2007 Sep; 43(8):757-63. PubMed ID: 17112773
[TBL] [Abstract][Full Text] [Related]
5. Value of fluoro-2-deoxy-D-glucose-positron emission tomography for detecting metastatic lesions in head and neck cancer.
Fogh SE; Kubicek GJ; Champ C; Intenzo C; Axelrod R; Keane WM; Machtay MM
Am J Clin Oncol; 2012 Aug; 35(4):311-5. PubMed ID: 22772424
[TBL] [Abstract][Full Text] [Related]
6. F-18 FDG-PET as a routine surveillance tool for the detection of recurrent head and neck squamous cell carcinoma.
Lee JC; Kim JS; Lee JH; Nam SY; Choi SH; Lee SW; Kim SB; Kim SY
Oral Oncol; 2007 Aug; 43(7):686-92. PubMed ID: 17112775
[TBL] [Abstract][Full Text] [Related]
7. PET/CT in the evaluation of patients with squamous cell cancer of the head and neck.
Goshen E; Davidson T; Yahalom R; Talmi YP; Zwas ST
Int J Oral Maxillofac Surg; 2006 Apr; 35(4):332-6. PubMed ID: 16280234
[TBL] [Abstract][Full Text] [Related]
8. Positron-emission tomography for surveillance of head and neck cancer.
Ryan WR; Fee WE; Le QT; Pinto HA
Laryngoscope; 2005 Apr; 115(4):645-50. PubMed ID: 15805874
[TBL] [Abstract][Full Text] [Related]
9. Detection of recurrent head and neck squamous cell carcinomas after radiation therapy with 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography.
Farber LA; Benard F; Machtay M; Smith RJ; Weber RS; Weinstein GS; Chalian AA; Alavi A; Rosenthal DI
Laryngoscope; 1999 Jun; 109(6):970-5. PubMed ID: 10369292
[TBL] [Abstract][Full Text] [Related]
10. Does 18fluoro-fluorodeoxyglucose positron emission tomography improve recurrence detection in patients treated for head and neck squamous cell carcinoma with negative clinical follow-up?
Salaun PY; Abgral R; Querellou S; Couturier O; Valette G; Bizais Y; Kraeber-Bodéré F
Head Neck; 2007 Dec; 29(12):1115-20. PubMed ID: 17636537
[TBL] [Abstract][Full Text] [Related]
11. Value of FDG PET in assessment of treatment response and surveillance in head-and-neck cancer patients after intensity modulated radiation treatment: a preliminary report.
Yao M; Graham MM; Smith RB; Dornfeld KJ; Skwarchuk M; Hoffman HT; Funk GF; Graham SM; Menda Y; Buatti JM
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1410-8. PubMed ID: 15590172
[TBL] [Abstract][Full Text] [Related]
12. Impact of FDG-PET to detect recurrence of head and neck squamous cell carcinoma.
Périé S; Hugentobler A; Susini B; Balogova S; Grahek D; Kerrou K; Montravers F; Chater PE; St Guily JL; Talbot JN
Otolaryngol Head Neck Surg; 2007 Oct; 137(4):647-53. PubMed ID: 17903585
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of efficacy and clinical impact of positron emission tomography with 18F fluoro-deoxyglucose in patients with suspicion of recurrent head and neck cancer or distant metastases].
Alvarez Pérez RM; Borrego Dorado I; Ruiz Franco-Baux JV; Vázquez Albertino RJ
Rev Esp Med Nucl; 2007; 26(1):30-9. PubMed ID: 17286946
[TBL] [Abstract][Full Text] [Related]
14. Direct comparison of F-18-FDG PET and ultrasound in the follow-up of patients with squamous cell cancer of the head and neck.
Goerres GW; Haenggeli CA; Allaoua M; Albrecht SR; Dulguerov P; Becker M; Allal AS; Lehmann W; Slosman DO
Nuklearmedizin; 2000 Dec; 39(8):246-50. PubMed ID: 11189902
[TBL] [Abstract][Full Text] [Related]
15. Positron emission tomography with 18F-fluorodeoxyglucose to predict pathologic response after induction chemotherapy and definitive chemoradiotherapy in head and neck cancer.
McCollum AD; Burrell SC; Haddad RI; Norris CM; Tishler RB; Case MA; Posner MR; Van den Abbeele AD
Head Neck; 2004 Oct; 26(10):890-6. PubMed ID: 15390197
[TBL] [Abstract][Full Text] [Related]
16. Posttreatment assessment of response using FDG-PET/CT for patients treated with definitive radiation therapy for head and neck cancers.
Andrade RS; Heron DE; Degirmenci B; Filho PA; Branstetter BF; Seethala RR; Ferris RL; Avril N
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1315-22. PubMed ID: 16750327
[TBL] [Abstract][Full Text] [Related]
17. 18F FDG PET/CT and Head and Neck Cancer: Patient Management and Outcomes.
Sheikhbahaei S; Marcus C; Subramaniam RM
PET Clin; 2015 Apr; 10(2):125-45. PubMed ID: 25829083
[TBL] [Abstract][Full Text] [Related]
18. Positron emission tomography (PET) in the management of oro-pharyngeal cancer.
Jones J; Farag I; Hain SF; McGurk M
Eur J Surg Oncol; 2005 Mar; 31(2):170-6. PubMed ID: 15698734
[TBL] [Abstract][Full Text] [Related]
19. The role of FDG PET in management of neck metastasis from head-and-neck cancer after definitive radiation treatment.
Yao M; Smith RB; Graham MM; Hoffman HT; Tan H; Funk GF; Graham SM; Chang K; Dornfeld KJ; Menda Y; Buatti JM
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):991-9. PubMed ID: 16099601
[TBL] [Abstract][Full Text] [Related]
20. Impact of FDG-PET/CT imaging on nodal staging for head-and-neck squamous cell carcinoma.
Murakami R; Uozumi H; Hirai T; Nishimura R; Shiraishi S; Ota K; Murakami D; Tomiguchi S; Oya N; Katsuragawa S; Yamashita Y
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):377-82. PubMed ID: 17321066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
